← Open Payments lookup

SARA KAISER: Open Payments

NPI 1720768518 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 27 payments from 9 companies in 2025. Trend: 2023 $162 · 2024 $1,228 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
ABBVIE INC.16$205
Takeda Pharmaceuticals U.S.A., Inc.2$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
ORPHALAN INC1$33
Phathom Pharmaceuticals, Inc.2$26
Madrigal Pharmaceuticals1$23
Celltrion USA Inc.1$17
GENZYME CORPORATION1$15
Janssen Biotech, Inc.1$15

Products named: RINVOQ, SKYRIZI, ENTYVIO, XIFAXAN, CUVRIOR, VOQUEZNA, REZDIFFRA, VEGZELMA.

Industry payments across UT — which companies pay providers there.